Rituximab Treatment for Autoimmune Diseases Intravenous immune globin (IVIG) is used to treat immunoglobulin deficiency and autoimmune diseases. However, other immune-modulating drugs, such as… November 21, 2018
Eculizumab for Treating Cold Agglutinin Disease Cold agglutinin disease (CAD) is a rare autoimmune disease caused by antibodies directed against red blood cell antigens, making them… October 24, 2018
Red Cell Exchange for Patients with Sickle Cell Disease: an AABB Report The Therapeutic Apheresis Subsection of the AABB, composed of 15 practicing apheresis physicians from 14 institutions, recently summarized how they… September 12, 2018
Emicizumab Therapy for Hemophilia A Treatment for hemophilia A usually involves intravenous injections of factor VIII multiple times a week. In 2012, emicizumab (a bispecific… September 5, 2018
Plasma Transfusions in Trauma Patients with Short Transport Times Since the US Food and Drug Administration may soon approve freeze-dried or lyophilized plasma, several trials have recently investigated the… August 9, 2018
Plasma Transfused During Transport to Hospital Saves Lives in Trauma Patients Nearly 50,000 Americans die from severe injuries each year, mainly from severe hemorrhage within two hours after the injury…. July 31, 2018
Transfusion Dependence for Leukemia Patients Shortens Hospice Stay Approximately 25,000 individuals in the United States die annually from leukemia. These individuals often require transfusions; however, hematologic oncologists have… June 6, 2018
WBC Alloimmunization Infrequent in Granulocyte Transfusions Neutropenia is characterized by abnormally low counts of neutrophils and is a common condition among patients receiving chemotherapy or hematopoietic… May 16, 2018
Rapid Transfusions after Combat Causalities Improves Chances of Survival Since bleeding is a major cause of death in combat causalities and civilian trauma cases, researchers recently examined the association… November 1, 2017
Patients with Moderate ADAMTS13 Deficiency have Increased Risk of Dying Thrombotic microangiopathies (TMAs) may develop from diverse group of etiologies. While activity levels less than 10% of ADAMTS13 help to… September 21, 2017
Special Transfusion Situations